Analysts Offer Predictions for BioRem FY2024 Earnings

BioRem Inc. (CVE:BRM) – Investment analysts at Cormark issued their FY2024 EPS estimates for BioRem in a research report issued to clients and investors on Tuesday, December 17th. Cormark analyst N. Boychuk anticipates that the company will post earnings per share of $0.19 for the year. Cormark has a “Moderate Buy” rating on the stock. Cormark also issued estimates for BioRem’s FY2025 earnings at $0.22 EPS and FY2026 earnings at $0.29 EPS.

BioRem Price Performance

Shares of CVE:BRM opened at C$2.95 on Friday. The company’s fifty day moving average price is C$2.83 and its 200-day moving average price is C$2.41. The company has a debt-to-equity ratio of 48.97, a current ratio of 1.57 and a quick ratio of 1.08. The firm has a market capitalization of C$46.32 million, a price-to-earnings ratio of 14.05 and a beta of 0.85. BioRem has a one year low of C$0.95 and a one year high of C$3.39.

Insider Buying and Selling

In related news, Director Derek Webb sold 120,000 shares of the firm’s stock in a transaction dated Monday, December 2nd. The stock was sold at an average price of C$2.93, for a total transaction of C$351,600.00. 1.90% of the stock is owned by company insiders.

About BioRem

BioRem Inc, a clean technology engineering company, designs, manufactures, distributes, and sells air pollution control systems that are used to eliminate odors, volatile organic compounds (VOCs), and hazardous air pollutants (HAPs). It offers biofilters for the removal of odors, H2S, VOCs, and HAPs; and biotrickling filters for applications of high levels of H2S or other water-soluble VOCs.